A development-stage biotechnology company focused on immunotherapy and regenerative medicine approaches for cancer and autoimmune diseases. Its research programs include cell-based therapies and gene-based treatments aimed at modulating the immune system. Investors tend to track the company for clin...
1 member of Congress has disclosed 1 trade in Regen BioPharma Inc (RGBP), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-02-03 | ROBERT J. WITTMAN | sell | $1K – $15K |